Use of glycolysis enhancing medications is associated with a decreased risk of developing Parkinson's disease

Abstract

Open access

Peer reviewed

Jacob E Simmering, Nandakumar Narayanan, Lei Liu, Michael J Welsh and Anton Pottegard

Pharmacoepidemiology and drug safety, Vol.29(Supplement 3), 4506

International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 36th

10/01/2020

DOI: 10.1002/pds.5114

Files and links (1)

url

https://doi.org/10.1002/pds.5114View

Published (Version of record) Open Access

Title: Subtitle: Use of glycolysis enhancing medications is associated with a decreased risk of developing Parkinson's disease
Creators: Jacob E Simmering
Nandakumar Narayanan
Lei Liu
Michael J Welsh
Anton Pottegard
Resource Type: Abstract
Publication Details: Pharmacoepidemiology and drug safety, Vol.29(Supplement 3), 4506
Conference: International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 36th
DOI: 10.1002/pds.5114
ISSN: 1053-8569
eISSN: 1099-1557
Language: English
Date published: 10/01/2020
Academic Unit: Neurology; Molecular Physiology and Biophysics; Pulmonary, Critical Care, and Occupational Medicine; Health Management and Policy; Iowa Neuroscience Institute; Pharmacy Practice and Science; Fraternal Order of Eagles Diabetes Research Center; Neurosurgery; Internal Medicine
Record Identifier: 9984259504002771

34 Record Views